InsidersTradesSigma
Follow the LIPELLA PHARMACEUTICALS INC stock price and the full insider trade history of the company, a listed equity based in United States. Shares trade on the US market, under the authority of SEC (Form 4). Market capitalisation: €152k. The latest transaction was filed on 27 December 2022 (J). Among the most active insiders: Chancellor Michael B. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
LIPELLA PHARMACEUTICALS INC is a company focused on developing innovative pharmaceutical treatments. It is listed on NASDAQ under the symbol XNAS.